Have a personal or library account? Click to login
Serum collected from rats with myocardial infarction increases extracellular matrix accumulation by myofibroblasts isolated from myocardial infarction scar Cover

Serum collected from rats with myocardial infarction increases extracellular matrix accumulation by myofibroblasts isolated from myocardial infarction scar

Open Access
|Jan 2022

References

  1. 1. Fomovsky GM, Thomopoulos S, Holmes JW. Contribution of extracellular matrix to the mechanical properties of the heart. J. Mol. Cell Cardio. 2010; 48(3): 490-496.10.1016/j.yjmcc.2009.08.003282383519686759
  2. 2. Fraccarollolo D, Galuppo P, Bauersachs J, Ertl G. Collagen accumulation aftermyocardial infarction: effects of ETA receptor blockade and implications for early remodeling. Cardiovasc. Res. 2002; 54(3): 559-567.10.1016/S0008-6363(02)00256-0
  3. 3. Abaco GM, Kaye AH. Integrins: Molecular determinants of glioma invasion. J. Clin. Neurosci. 2007; 14(11): 1041-1048.10.1016/j.jocn.2007.06.019
  4. 4. Van der Flier A, Sonnenberg A. Fuction and interactions of integrines. Cell Tissue Res. 2001; 305(03): 285-298.10.1007/s00441010041711572082
  5. 5. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: Integrating signals from front to back. Science. 2003; 302(5651): 1704-1709.10.1126/science.109205314657486
  6. 6. Gałdyszyńska M, Bobrowska E, Lekka M, Radwańska P, Piera L, Szymański J, Drobnik J. The stiffness-controlled release of interleukin-6 by cardiac fibroblasts is dependent on integrin α2β1. J Cell Mol Med. 2020, Dec; 24(23): 13853–13862.10.1111/jcmm.15974775405933124775
  7. 7. Drobnik J, Ciosek J, Jakubowski L. The role of the connective tissue in healing process in myocardial infarction. Kardiologia Polska 2005; 63(4 Suppl.2): 428-439.
  8. 8. Dąbrowski R, Drobnik J. The effect of disodium cromoglycate on the skin wound healing and collagen content in the wounds of rats. Acta Physiol. Pol. 1990; 41(4-6): 95-98.
  9. 9. Wolak M, Bojanowska E, Staszewska T, Ciosek J, Juszczak M, Drobnik J. The role of histamine in the regulation of the viability, proliferation and Transforming Growth Factor β1 secretion of rat wound fibroblasts. Pharmacol. Rep. 2017; 69: 314-321.10.1016/j.pharep.2016.11.006
  10. 10. Frangogiannis NG, Perrard JL, Mendoza LH, Burns AR, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. Stem cell factor induction is associated with mast cell accumulation with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 1998; 98(7): 687-698.10.1161/01.CIR.98.7.687
  11. 11. Akiyama-Uchida Y, Ashizawa N, Ohtsuru A, Seto S, Tsukazaki T, Kikuchi H, Yamashita S, Yano K. Norepinephine enhances fibrosis mediated by TGF-β in cardiac fibro-blasts. Hypertension 2002; 40(2): 148-154.10.1161/01.HYP.0000025443.61926.12
  12. 12. Klett CP, Palmer AA, Dirig DM, Gallagher AM, Riosecco-Camacho N, Printz MP. Evidence for differences in cultured left ventricular fibroblasts populations isolated from spontaneously hypertensive and Wistar-Kyoto rats. J. Hypertens. 1995; 13(12 Pt 1): 1421-1431.10.1097/00004872-199512000-00008
  13. 13. Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KTEffects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol. Cell Biochem. 1996; 154(2): 171-178.10.1007/BF002267858717431
  14. 14. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension and cardiac fibrosis. J. Clin. Invest. 1994; 93(6): 2578-2583.10.1172/JCI1172692944888200995
  15. 15. Kapoun AM, Liang F, O’Young G, Damm DL, Quon D, White RT, Munson K, Lam A, Shreiner GF, Protter AA. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation and inflammation. Circ. Res. 2004; 94(4): 453-461.10.1161/01.RES.0000117070.86556.9F
  16. 16. Dubey RK, Gillespie DG, Jackson EK. Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: Role of A2B receptors. Hypertension 1998; 31(4): 943-948.10.1161/01.HYP.31.4.943
  17. 17. Porter KE, Tuner NA. Cardiac fibroblasts. At the heart of myocardial remodeling. Pharm. Ther. 2009; 123(2): 255-278.
  18. 18. Drobnik J, Owczarek K, Piera L, Tosik D, Olczak S, Ciosek J, Hrabec E. Melatonin-induced augmentation of collagen deposition in cultures of fibroblasts and myofibroblasts is blocked by luzindole – melatonin membrane receptors inhibitor. Pharmacol. Rep. 2013; 65(3): 642-649.10.1016/S1734-1140(13)71041-7
  19. 19. Piera L, Olczak S, Kun T, Gałdyszyńska M, Ciosek J, Szymański J, Drobnik J. Disruption of histamine/H3receptor signal reduces collagen deposition in cultures scar myofibroblasts. J Physiol Pharmacol 2019; 70(2): 239-247.
  20. 20. Farndale RW, Buttle DJ, Barret AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use dimethylmethylene blue. Biochem. Biophys. Acta. 1986; 883(2): 173-177.10.1016/0304-4165(86)90306-5
  21. 21. Cheng T, Yue M, Aslam MN, Wang X, Shekhawat G, Varani J, Schuger L. Neuronal Protein 3.1 Deficiency leads to reduced cutaneous scar collagen deposition and tensile strength due to impaired transforming growth factor-β1 to -β3 translation. Am. J. Pathol. 2017; 187(2): 292-303.10.1016/j.ajpath.2016.10.004
  22. 22. Cleutiens JP, Verluyten MJ, Smits JF, Daemen M.J. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 1995; 147(2): 325-338.
  23. 23. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009; 123(2): 255-278.10.1016/j.pharmthera.2009.05.002
  24. 24. Anand IS, Ferrari R, Kalra GS, Wah PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes and plasma hormones in untreated congestive cardiac failure. Circulation 1989; 80: 299-305.10.1161/01.CIR.80.2.299
  25. 25. Sakai S, Miyauchi T, Kobayashi M, Goto K. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996; 384(6607): 353-355.10.1038/384353a0
  26. 26. Kayle DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympatetic nervous activity in the failing human heart. J. Am. Coll. Cardiol. 1995; 26(5): 1257-1263.10.1016/0735-1097(95)00332-0
  27. 27. Thibault G, Nemer M, Drouin J, Lavigne JP, Ding J, Charbonneau C, Garcia R, Genest J, Jasmin G, Sole M. Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopatic hamsters with heart failure. Circ. Res. 1989; 65(1): 71-82.10.1161/01.RES.65.1.71
  28. 28. Kulke M, Geist N, Friedrichs W, Langel W. Molecular dynamics simulations on networks of heparin and collagen. Proteins 2017; 85(6): 1119-1130.10.1002/prot.25277
  29. 29. Chen S, Young MF, Chakravarti S, Birk DE. Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly. Matrix Biol. 2014; 35: 103-111.10.1016/j.matbio.2014.01.004
  30. 30. Reese SP, Underwood CJ, Weiss JA. Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. Matrix Biol. 2013;32(7-8):414-423.10.1016/j.matbio.2013.04.004
  31. 31. Pietraszek K, Chatron-Colliet A, Brézillon S, Perreau C, Jakubiak-Augustyn A, Krotkiewski H, Maquart FX, Wegrowski Y. Lumican: a new inhibitor of matrix metalloproteinase-14 activity. FEBS Lett. 2014; 588(23): 4319-4324.10.1016/j.febslet.2014.09.040
  32. 32. Drobnik J, Szczepanowska A, Dąbrowski R. Temporary augmentation of glycosaminoglycans content in the heart after left coronary artery ligation. Pathophysiology 2004; 11(1): 35-39.10.1016/j.pathophys.2004.01.024
  33. 33. Dąbrowski R, Maslinski C. The effect of histamine on collage formation and collage polymerisation In the skin wounds healing of guinea pigs. Life Sci. 1970; 9: 189-202.10.1016/0024-3205(70)90068-8
  34. 34. Saito T, Tazawa K, Yokoyama Y, Saito M. Surgical stress inhibits the growth of fibroblasts through the elevation of plasma catecholamine and cortisol concentrations. 1997; 27(7): 627-631.10.1007/BF02388219
  35. 35. Anitua E, Muruzabal F, de la Fuente M, Riestra A, Merayo-Lloves J, Orive G. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model. Exp. Eye Res. 2016; 151: 115-121.10.1016/j.exer.2016.08.01227567559
  36. 36. Leicht M, Briest W, Zimmer HG. Regulation of norepinerine-induced proliferation in cardiac fibroblasts by inter-leukin-6 and p42/p44 mitogen activated protein kinase. Mol. Cell Biochem. 2003; 243: 65-72.10.1023/A:1021655023870
  37. 37. Turner NA, Porter KE, Smith WH, White HL, Ball SG, Balmforth A. Chronic β2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. Cardiovasc. Res. 2003; 57(3): 784-792.10.1016/S0008-6363(02)00729-0
  38. 38. Yang Y, Chen S, Tao L, Gan S, Luo H, Xu Y, Shen X.Inhibitory Effects of Oxymatrine on Transdifferentiation of Neonatal Rat Cardiac Fibroblasts to Myofibroblasts Induced by Aldosterone via Keap1/Nrf2 Signaling Pathways In Vitro. Med Sci Monit. 2019; 25: 5375-5388.10.12659/MSM.915542666294331325292
  39. 39. Janbandhu V, Tallapragada V, Patrick R, Li Y, Abeygunawardena D, Humphreys DT, Martin E, Ward AO, Contreras O, Farbehi N, Yao E, Du J, Dunwoodie SL, Bursac N, Harvey RP. Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction. Cell Stem Cell 2021; S1934-5909(21): 00421-5.10.1016/j.stem.2021.10.009902192734762860
  40. 40. Huntley BK, Ichiki T, Sangaralingham SJ, Chen HH, Burnett JC Jr. B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts. J Cell Physiol. 2010; 225: 251-5.10.1002/jcp.22253383553520506274
  41. 41. Gu Y, Yang DK, Spinas E, Kritas SK, Saggini A, Caraffa A, Antinolfi P, Saggini R, Conti P. Role of TNF in mast cell neuroinflammation and pain. J. Biol. Regul. Homeost. Agents. 2015; 29(4): 787-791.
Language: English
Page range: 1 - 8
Published on: Jan 24, 2022
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Lucyna Piera, Jacek Szymański, Tomasz Kun, Anna Krzymińska, Marlena Juszczak, Jacek Drobnik, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.